Novo Nordisk (NVO) Partners With Hims & Hers, Here’s What You Need to Know

Group 1 - Novo Nordisk A/S has partnered with Hims & Hers to provide access to its GLP-1 drugs, Ozempic and Wegovy, through Hims & Hers' platform [1] - Hims & Hers will offer FDA-approved Ozempic injections and Wegovy in both tablet and injection forms at competitive self-pay prices, ceasing the sale of compounded GLP-1s [2] - Novo Nordisk is dropping its patent lawsuit against Hims & Hers, which is seen as a positive move for patients by prioritizing FDA-approved medications over unapproved alternatives [3] Group 2 - Novo Nordisk A/S is a global healthcare leader in diabetes care, obesity management, haemophilia care, and rare endocrine disorders [4]